Opko Signs Contract With Three Insurers | GenomeWeb

NEW YORK (GenomeWeb) – Opko Health said today that it has signed contracts with three health insurers for coverage of the firm's testing services, including the 4Kscore Test for prostate cancer. 

The contracts are with Stratose, Three Rivers Provider Network, and Fortified Provider Network. Cumulatively, the contracts will provide more than 25 million people with access to Opko Lab's testing services, the Miami-based firm said. 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: genetic target for urothelial bladder cancer treatment, and more.

At the Conversation, the University of Oxford's Michael Macklay writes that learning genetic risk of disease is a personal decision.

Two dozen scientific organizations have endorsed the March for Science, according to ScienceInsider.

Researchers in Japan describe a chimpanzee with a chromosomal abnormality similar to human Down syndrome, Mashable reports.

Sponsored by

This webinar will discuss how next-generation sequencing and digital PCR can be used in a complementary manner for liquid biopsies in order to improve patient care.

Sponsored by
Personal Genome Diagnostics

This webinar will discuss genomic methods to elucidate the molecular mechanisms underlying acquired resistance to immuno-oncology (IO) therapies.


This webinar describes the optimization and validation of two commercially available next-generation sequencing assays that may be used to guide personalized cancer treatment.